Medicine Innovates Medicine Innovates: Delivering innovations in medicine to the world for better health and prosperity
Targeted Antimicrobial Therapies: Harnessing Niche-Specific Metabolic Vulnerabilities in Pathogens
Polyoxypregnane Aryl Esters as Non-Substrate P-gp Modulators
Significance Reference Guo Y, Wu H, Wu T, Shen X, Hu Y. Polyoxypregnane Aryl Esters Prepared from Metaplexis japonica (Thunb.) Makino and Their Role in Reversing Multidrug Resistance in HepG2/Dox Cells. Pharmaceuticals (Basel). 2025;18(8):1187. doi: 10.3390/ph18081187.
Read More »Transforming Oral Cancer Therapies: Enhanced Bioavailability and Reduced Variability with Innovative Drug Formulations
Transforming Bioequivalence Assessment with the Finite Absorption Time Concept
Targeting EGFR Drug Resistance in NSCLC: Identification of Alternative Inhibitors through Structural Analysis and Virtual Screening
RY103: A Novel IDO1 Inhibitor Targeting Immune Suppression and Angiogenesis in Glioblastoma Therapy
Unexpected Impact of Roxadustat on Thyroid Function: New Insights into HIF-PH Inhibitors in Renal Anemia
